Axillary hyperhidrosis: A review of the extent of the problem and treatment modalities

Singh, Sanjay; Davis, Harriet; Wilson, Paul

doi:10.1016/j.surge.2015.03.003

Cited by 27 publications

(14 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Patients with PH often also have axillary and plantar hyperhidrosis. Sympathectomy is not the preferred treatment for mild axillary hyperhidrosis because of side effects [23]. The treatment of mild axillary hyperhidrosis includes topical aluminium chloride, iontophoresis, injection of botulinum toxin A, oral medication, surgical methods, laser treatment, and microwave thermolysis, with the latter two treatments particularly being accepted by more patients because of their positive effects, less pain, and less trauma [24].…”

Section: Discussionmentioning

confidence: 99%

A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating.

Xie¹,

Lu²,

Zhu³

et al. 2019

Videosurgery and Other Miniinvasive Techniques

View full text Add to dashboard Cite

Introduction: Thoracoscopic sympathectomy (TS) has been proven to be a safe and effective treatment for primary palmar hyperhidrosis (PH). However, the complications include compensatory hyperhidrosis (CH), and over-dry hands may occur in some patients after TS. Aim: To compare the therapeutic effect of T3 and T4 TS on primary PH and primary PH with axillary and plantar sweating. Material and methods: We retrospectively analyzed 100 patients with PH who had undergone T3 (group A, n = 49) or T4 (group B, n = 51) TS in our department, with at least 1 year of postoperative follow-up. Results: At discharge, no major complications or deaths occurred in either group. The condition of sweaty hands was fully improved in 44 of 49 patients in group A and all patients in group B, with a significant difference (p = 0.031). After 12 months of follow-up, 18 (36.7%) patients in group A and 4 (7.8%) patients in group B developed CH, 16 (48.5%) patients in group A and 24 (77.4%) patients in group B had improved axillary sweating, with a significant difference (p < 0.05). The satisfaction rate of group B was significantly higher than that of group A (p < 0.01). Conclusions: Both T3 and T4 TS were safe and effective treatments for PH patients, but the incidence of CH in T4 TS was lower than that in T3 TS. T3 TS may be more suitable for patients with severe PH, while T4 TS had a better therapeutic effect on PH patients with axillary sweating.

show abstract

Section: Discussionmentioning

confidence: 99%

A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating.

Xie¹,

Lu²,

Zhu³

et al. 2019

Videosurgery and Other Miniinvasive Techniques

View full text Add to dashboard Cite

show abstract

“…Several treatment options for axillary hyperhidrosis exist: topical antiperspirants, oral medications, injectable agents (ie, botulinum toxin), surgery, and laser procedures. However, noninvasive treatments such as botulinum toxin injections and topicals offer only temporary solutions, and invasive treatments such as thoracic sympathectomy, subcutaneous shaving, and tumescent liposuction may lead to adverse effects, including compensatory hyperhidrosis, significant scarring, infection, and restricted arm movement 8, 9…”

Section: Discussionmentioning

confidence: 99%

A case of axillary bromhidrosis secondary to trimethylaminuria successfully treated with microwave-based therapy

Patel

Fernandes

et al. 2019

JAAD Case Reports

View full text Add to dashboard Cite

“…In contrast, intradermal injections of botulinum toxin type A reduces axillary hyperhidrosis effectively (82–87%) and is generally well‐tolerated. The disadvantages of using Botulinum toxin type A is its limited period of effectiveness (4–6 months) and the need for multiple, potentially painful injections to be administered by trained clinicians …”

Section: Discussionmentioning

confidence: 99%

Topical glycopyrrolate reduces axillary hyperhidrosis

Baker

2016

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

Axillary hyperhidrosis: A review of the extent of the problem and treatment modalities

Cited by 27 publications

References 34 publications

A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating.

A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating.

A case of axillary bromhidrosis secondary to trimethylaminuria successfully treated with microwave-based therapy

Topical glycopyrrolate reduces axillary hyperhidrosis

Contact Info

Product

Resources

About